Science Explorer Back to mapMap
Discussion
Company · Beverly Cove · United States

Innovation Pharmaceuticals (United States)

ipharminc.comROR OpenAlex
Research works
16
◆ 1% vs 2018-21
Citations
288
18.3 per fractional work
Top-10% rate
6.4%
all institutions 10.0%
Open access
24%
world 40%
International
38%
world 18%
Innovation Pharmaceuticals (United States)

Not ranked overall: Innovation Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Innovation Pharmaceuticals (United States) work in?

In all years, 38% of research at Innovation Pharmaceuticals (United States) is in Life Sciences, 31% in Physical Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (31%), Medicine (28%), Chemistry (20%). It does 1.7× the world's share of Life Sciences.

Life Sciences: 6 fractional works · 38.2% of its workBiochemistry, Genetics and Molecular Biology: 5 fractional works · 31.0% of its workMolecular Biology: 2 fractional works · 14.3% of its workCancer Research: 1 fractional works · 6.9% of its workBiotechnology: 1 fractional works · 5.4% of its workClinical Biochemistry: 0 fractional works · 2.1% of its workGenetics: 0 fractional works · 2.1% of its workBiophysics: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 3.6% of its workPharmaceutical Science: 1 fractional works · 3.6% of its workNeuroscience: 0 fractional works · 1.8% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.1% of its workBehavioral Neuroscience: 0 fractional works · 0.7% of its workImmunology and Microbiology: 0 fractional works · 1.6% of its workMicrobiology: 0 fractional works · 1.2% of its workImmunology: 0 fractional works · 0.4% of its workAgricultural and Biological Sciences: 0 fractional works · 0.3% of its workPlant Science: 0 fractional works · 0.3% of its workPhysical Sciences: 5 fractional works · 31.1% of its workChemistry: 3 fractional works · 19.9% of its workOrganic Chemistry: 3 fractional works · 18.8% of its workInorganic Chemistry: 0 fractional works · 1.1% of its workEngineering: 1 fractional works · 7.0% of its workElectrical and Electronic Engineering: 0 fractional works · 2.7% of its workMechanical Engineering: 0 fractional works · 2.1% of its workMechanics of Materials: 0 fractional works · 2.1% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 0 fractional works · 2.2% of its workArtificial Intelligence: 0 fractional works · 1.8% of its workComputational Theory and Mathematics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMaterials Science: 0 fractional works · 2.1% of its workElectronic, Optical and Magnetic Materials: 0 fractional works · 1.1% of its workMaterials Chemistry: 0 fractional works · 1.1% of its workHealth Sciences: 4 fractional works · 28.3% of its workMedicine: 4 fractional works · 28.3% of its workOncology: 2 fractional works · 12.3% of its workInfectious Diseases: 1 fractional works · 3.4% of its workPsychiatry and Mental health: 0 fractional works · 3.2% of its workEpidemiology: 0 fractional works · 2.3% of its workGastroenterology: 0 fractional works · 2.1% of its workHematology: 0 fractional works · 1.6% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.1% of its workPharmacology: 0 fractional works · 1.0% of its workGenetics: 0 fractional works · 0.5% of its workNephrology: 0 fractional works · 0.4% of its workPathology and Forensic Medicine: 0 fractional works · 0.4% of its workSocial Sciences: 0 fractional works · 2.4% of its workBusiness, Management and Accounting: 0 fractional works · 1.2% of its workAccounting: 0 fractional works · 0.7% of its workMarketing: 0 fractional works · 0.5% of its workEconomics, Econometrics and Finance: 0 fractional works · 1.2% of its workFinance: 0 fractional works · 0.7% of its workEconomics and Econometrics: 0 fractional works · 0.5% of its workALL ITS WORKInnovationPharmaceuticals…16fractional works, all years
Life Sciences38%Physical Sciences31%Health Sciences28%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology531.0%
    2. Pharmacology, Toxicology and Pharmaceutics13.6%
    3. Neuroscience01.8%
    4. Immunology and Microbiology01.6%
    5. Agricultural and Biological Sciences00.3%
    1. Chemistry319.9%
    2. Engineering17.0%
    3. Computer Science02.2%
    4. Materials Science02.1%
    1. Medicine428.3%
    1. Business, Management and Accounting01.2%
    2. Economics, Econometrics and Finance01.2%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.18× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.72× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 1.96× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 28.00× its world share, 1 worksPharmacology, Toxico…Chemistry: 34.16× its world share, 3 worksChemistryComputer Science: 0.41× its world share, 0 worksComputer ScienceEngineering: 0.12× its world share, 0 worksEngineeringMaterials Science: 1.70× its world share, 0 worksMaterials ScienceMedicine: 0.35× its world share, 0 worksMedicineBusiness, Management and Accounting: 1.07× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 1.61× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 34.2×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Chemistry34.16×3 works
  2. Pharmacology, Toxicology and Pharmaceutics28.00×1 works
  3. Immunology and Microbiology1.96×0 works
  4. Biochemistry, Genetics and Molecular Biology1.72×0 works
  5. Materials Science1.70×0 works
  6. Economics, Econometrics and Finance1.61×0 works
  7. Business, Management and Accounting1.07×0 works
  8. Computer Science0.41×0 works
  9. Medicine0.35×0 works
  10. Agricultural and Biological Sciences0.18×0 works
  11. Engineering0.12×0 works

What are the most cited papers from Innovation Pharmaceuticals (United States)?

The most cited paper from Innovation Pharmaceuticals (United States) is "Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture" (Allison Bakovic, Kenneth H. Risner, Nishank Bhalla et al., 2021), with 54 citations. Next come "Brilacidin, a COVID-19 Drug Candidate, Exhibits Potent In Vitro Antiviral Activity Against SARS-CoV-2" (15) and "Brilacidin, a Non-Peptide Defensin-Mimetic Molecule, Inhibits SARS-CoV-2 Infection by Blocking Viral Entry." (13).

Most cited papers
#PaperReleasedCitations
1 Brilacidin Demonstrates Inhibition of SARS-CoV-2 in Cell Culture Allison Bakovic, Kenneth H. Risner, Nishank Bhalla et al. · Viruses Open access 9 Feb 2021 54
2 Brilacidin, a COVID-19 Drug Candidate, Exhibits Potent In Vitro Antiviral Activity Against SARS-CoV-2 Allison Bakovic, Kenneth H. Risner, Nishank Bhalla et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 30 Oct 2020 15
3 Brilacidin, a Non-Peptide Defensin-Mimetic Molecule, Inhibits SARS-CoV-2 Infection by Blocking Viral Entry. Chuan Xu, Annie Wang, William J. Honnen et al. · PubMed Open access Apr 2022 13
4 Application of Artificial Intelligence/Machine Vision & Learning for the Development of a Live Single-cell Phenotypic Biomarker Test to Predict Prostate Cancer Tumor Aggressiveness. Jonathan S. Varsanik, Michael S. Manak, Matthew J. Whitfield et al. · PubMed Open access 2020 2
5 Enhancing the explainability of the default probability model using the logic learning machine: A comparison between native “white boxes” machine learning techniques Pier Giuseppe Giribone, Serena Berretta, Michelangelo Fusaro et al. · International Journal of Financial Engineering 27 Jun 2025 1
All 11 most cited papers, with filters and sorting

Which research topics does Innovation Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Radical Photochemical Reactions, Fluorine in Organic Chemistry, Catalytic C–H Functionalization Methods and Catalytic Cross-Coupling Reactions.

Radical Photochemical Reactions: 1 fractional worksFluorine in Organic Chemistry: 1 fractional worksCatalytic C–H Functional…0Catalytic C–H Functionalization Methods: 0 fractional worksCatalytic Cross-Coupling…0Catalytic Cross-Coupling Reactions: 0 fractional worksCyclopropane Reaction Me…0Cyclopropane Reaction Mechanisms: 0 fractional worksSulfur-Based Synthesis T…0Sulfur-Based Synthesis Techniques: 0 fractional worksCatalytic Alkyne Reactions0Catalytic Alkyne Reactions: 0 fractional worksSynthetic Organic Chemistry Methods: 0 fractional worksClick Chemistry and Applications: 0 fractional worksMagnetism in coordination complexes: 0 fractional works
Organic ChemistryPharmaceutical ScienceElectronic, Optical and Magnetic Materials

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Radical Photochemical Reactions Organic Chemistry 1 works
  2. 2 Fluorine in Organic Chemistry Pharmaceutical Science 1 works
  3. 3 Catalytic C–H Functionalization Methods Organic Chemistry 0 works
  4. 4 Catalytic Cross-Coupling Reactions Organic Chemistry 0 works
  5. 5 Cyclopropane Reaction Mechanisms Organic Chemistry 0 works
  6. 6 Sulfur-Based Synthesis Techniques Organic Chemistry 0 works
  7. 7 Catalytic Alkyne Reactions Organic Chemistry 0 works
  8. 8 Synthetic Organic Chemistry Methods Organic Chemistry 0 works
  9. 9 Click Chemistry and Applications Organic Chemistry 0 works
  10. 10 Magnetism in coordination complexes Electronic, Optical and Magnetic Materials 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available23.6%not open76.4%

World: 40% of research is openly available.

with international co-authors37.7%domestic only62.3%

World: 18% is written across borders.

How has Innovation Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 1% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Innovation Pharmaceuticals (United States) as a percentage of every work published that year, 0.0000029% in 2024.

still counting0.000050%0.00010%Innovation Pharmaceuticals (United States)0.000028% in 2025200020102020

Fractional works of Innovation Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Beverly Cove

All research institutions in Beverly Cove

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Innovation Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.